1) DepoFoam
多室脂质体
1.
Preparation and characterization of pulmonary targeting DepoFoam loaded MR contrast media: gadopentetate dimeglumine;
肺靶向性多室脂质体磁共振对比剂的制备及其特性分析
2) Unilamellar,single compartment liposome
单室脂质体
3) multivesicular liposomes
多囊脂质体
1.
Preparation of tyroserlenutide multivesicular liposomes and drug release in vitro;
酪丝亮肽多囊脂质体的制备和体外释放研究
2.
Determination of entrapment efficiency of bulleyaconitine A multivesicular liposomes;
草乌甲素多囊脂质体包封率的测定
5) Mmultivesicular liposomes
多泡脂质体
6) Multivesicular liposome
多囊脂质体
1.
Aim To explore simple method to determine the interaction between peptide and lipid bilayer and then decide how to modify formulation from classic DepoFoam technology, multivesicular liposome of LXT-101(DepoLXT-101) was prepared as a modal, and resulting products were characterized by in vitro evaluation.
目的采用物理测定方法探讨正电性合成多肽LXT-101与磷脂膜的相互作用并进行LXT-101多囊脂质体(DepoLXT-101)的处方工艺筛选,同时进行体外评价。
2.
Using a simple method to determine the interaction between peptide and lipid bilayer and then deciding how to modify formulation from classic DepoFoam technology, multivesicular liposome of LXT-101 (DepoLXT-101) was prepared and characterized by in vitro evaluation.
采用物理测定方法探讨正电性合成多肽LXT-101与磷脂膜的相互作用并进行LXT-101多囊脂质体(DepoLXT-101)的处方工艺筛选,同时进行体外评价。
3.
The effects of L-lysine,polyvinyl alcohol and sodium alginate as co-emulsifier on the diameter and encapsulation effi ciency of the multivesicular liposomes were investigated.
以拓扑替康为模型药物,采用复乳法制备多囊脂质体,考察了分别以L-赖氨酸、聚乙烯醇和海藻酸钠为助乳化剂对脂质体粒径和包封率的影响。
补充资料:脂质体
分子式:
分子量:
CAS号:
性质:一种水不溶性的、极性磷脂质组成的双层碟状液晶分子,在水中可形成一个或数个同心的脂质双分子层。脂质体可包蔽水和水溶性药物,也可将脂溶性药物结合在双分子层的脂质部分。脂质体在结构上可分为单层脂质体(直径约25纳米)、多层脂质体(约100纳米)和大脂质体(约0.13微米左右)。其特点是可减少剂量、降低毒性,减轻变态反应,可延缓药物的释放,减少药物在体内消除程度,提高药物的治疗效果,改变药物在组织中的分布,增强药物的选择性作用。
分子量:
CAS号:
性质:一种水不溶性的、极性磷脂质组成的双层碟状液晶分子,在水中可形成一个或数个同心的脂质双分子层。脂质体可包蔽水和水溶性药物,也可将脂溶性药物结合在双分子层的脂质部分。脂质体在结构上可分为单层脂质体(直径约25纳米)、多层脂质体(约100纳米)和大脂质体(约0.13微米左右)。其特点是可减少剂量、降低毒性,减轻变态反应,可延缓药物的释放,减少药物在体内消除程度,提高药物的治疗效果,改变药物在组织中的分布,增强药物的选择性作用。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条